NPI: 1871713495 · HARTFORD, CT 06105 · Emergency Medicine Physician · NPI assigned 04/26/2007
Authorized official HARRIS, JAMES controls 20+ related entities in our dataset. Read more
| Authorized Official | HARRIS, JAMES (REGIONAL DIRECTOR OF REIMBURSEMENT) |
| Parent Organization | TRINITY HEALTH OF NEW ENGLAND CORPORATION INC |
| NPI Enumeration Date | 04/26/2007 |
Other providers sharing the same authorized official: HARRIS, JAMES
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 1,067,261 | $38.18M |
| 2019 | 1,185,699 | $40.55M |
| 2020 | 1,002,945 | $35.66M |
| 2021 | 1,178,028 | $42.28M |
| 2022 | 1,109,115 | $41.46M |
| 2023 | 1,013,265 | $37.27M |
| 2024 | 855,555 | $30.99M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 97,958 | 82,745 | $50.26M |
| J2350 | Injection, ocrelizumab, 1 mg | 1,930 | 1,645 | $31.39M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 80,575 | 70,824 | $24.72M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 196,031 | 142,510 | $18.23M |
| J2323 | Injection, natalizumab, 1 mg | 4,105 | 3,489 | $15.67M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 74,404 | 65,407 | $15.32M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 70,021 | 56,701 | $9.82M |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 6,029 | 5,357 | $4.38M |
| J9271 | Injection, pembrolizumab, 1 mg | 711 | 500 | $4.16M |
| 93458 | 2,364 | 2,224 | $3.67M | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 15,990 | 9,873 | $3.44M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 20,541 | 18,458 | $3.00M |
| 70450 | Computed tomography, head or brain; without contrast material | 23,781 | 21,055 | $2.99M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 42,011 | 36,197 | $2.80M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 22,600 | 17,363 | $2.65M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 5,256 | 4,932 | $2.54M |
| 96361 | Intravenous infusion, hydration; each additional hour | 47,697 | 38,831 | $2.20M |
| 27447 | 606 | 506 | $2.18M | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 16,007 | 13,868 | $2.17M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 15,945 | 13,733 | $1.98M |
| 71046 | Radiologic examination, chest; 2 views | 38,419 | 34,302 | $1.96M |
| 96375 | Therapeutic injection; each additional sequential IV push | 48,366 | 38,080 | $1.85M |
| G0390 | Trauma response team associated with hospital critical care service | 2,624 | 2,359 | $1.74M |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 2,566 | 2,390 | $1.72M |
| 59025 | Fetal non-stress test | 10,131 | 3,594 | $1.49M |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 14,010 | 13,312 | $1.48M |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 6,852 | 6,252 | $1.38M |
| 78815 | Positron emission tomography (PET) for limited area imaging | 1,990 | 1,787 | $1.29M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 5,247 | 4,727 | $1.26M |
| 77412 | 11,988 | 988 | $1.18M | |
| 76801 | 11,154 | 9,375 | $1.13M | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 2,588 | 2,262 | $1.11M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 44,368 | 38,333 | $1.04M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 44,334 | 38,307 | $1.04M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 8,099 | 7,409 | $1.03M |
| 77334 | 1,371 | 840 | $892K | |
| 71045 | Radiologic examination, chest; single view | 21,621 | 18,780 | $874K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 1,580 | 1,528 | $828K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 7,659 | 6,793 | $826K |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | 2,713 | 2,398 | $761K |
| 76830 | Ultrasound, transvaginal | 7,736 | 7,083 | $749K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 7,852 | 7,226 | $737K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 2,928 | 2,682 | $730K |
| J0897 | Injection, denosumab, 1 mg | 928 | 784 | $710K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 10,639 | 8,259 | $704K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 2,433 | 2,157 | $659K |
| 94060 | 3,935 | 3,624 | $628K | |
| 62323 | 1,597 | 1,508 | $623K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 29,753 | 25,911 | $619K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 5,850 | 5,288 | $598K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 282,256 | 208,106 | $568K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 5,484 | 5,020 | $562K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 7,114 | 6,547 | $559K |
| 86900 | 34,378 | 26,872 | $519K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 4,015 | 3,537 | $518K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 674 | 635 | $483K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 13,578 | 11,617 | $479K |
| 58558 | 300 | 266 | $479K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 4,591 | 4,156 | $468K |
| 84443 | Thyroid stimulating hormone (TSH) | 56,385 | 46,452 | $467K |
| 41899 | Unlisted procedure, dentoalveolar structures | 987 | 670 | $420K |
| 96415 | 5,238 | 3,779 | $415K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 731 | 694 | $411K |
| J2505 | Injection, pegfilgrastim, 6 mg | 160 | 107 | $409K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1,971 | 1,131 | $380K |
| 36430 | 3,167 | 1,857 | $371K | |
| 82947 | 198,135 | 148,089 | $362K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 4,923 | 4,029 | $350K |
| 93971 | 5,401 | 4,864 | $346K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 20,418 | 16,292 | $346K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 47,502 | 33,791 | $336K |
| 93970 | 2,807 | 2,550 | $330K | |
| 36415 | Collection of venous blood by venipuncture | 375,906 | 261,044 | $327K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 2,341 | 2,159 | $325K |
| 76642 | 5,777 | 5,169 | $321K | |
| 76825 | 727 | 603 | $318K | |
| 70496 | 2,836 | 2,531 | $307K | |
| 10061 | 1,053 | 982 | $307K | |
| 95811 | 415 | 388 | $299K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 23,469 | 19,723 | $299K |
| 83036 | Hemoglobin; glycosylated (A1C) | 60,793 | 51,368 | $299K |
| 20610 | 1,595 | 1,324 | $279K | |
| 71250 | 5,169 | 4,661 | $273K | |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 83 | 55 | $261K |
| 82310 | 199,687 | 148,952 | $256K | |
| 83718 | 38,685 | 33,824 | $250K | |
| 77336 | 3,427 | 1,218 | $241K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 37,915 | 28,988 | $239K |
| J1950 | Injection, leuprolide acetate (for depot suspension), per 3.75 mg | 164 | 142 | $237K |
| 76641 | 2,671 | 2,514 | $229K | |
| 97597 | 2,287 | 1,325 | $226K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 8,961 | 8,345 | $221K |
| 87660 | 15,836 | 13,339 | $221K | |
| 87510 | 15,846 | 13,341 | $220K | |
| 87480 | 15,847 | 13,342 | $220K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 20,284 | 18,021 | $217K |
| 72141 | 2,025 | 1,833 | $215K | |
| 82607 | 29,073 | 22,985 | $211K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 7,641 | 5,072 | $209K |
| 76770 | 3,128 | 2,814 | $208K | |
| 77066 | Tomosynthesis, mammo | 1,866 | 1,697 | $207K |
| 90791 | Psychiatric diagnostic evaluation | 3,778 | 3,274 | $201K |
| 82040 | 81,732 | 62,905 | $201K | |
| 82247 | 126,544 | 100,523 | $197K | |
| Q5108 | Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg | 104 | 69 | $195K |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 1,714 | 1,601 | $194K |
| 36561 | 149 | 118 | $193K | |
| 77300 | 468 | 377 | $193K | |
| 27130 | 64 | 42 | $184K | |
| 77295 | 283 | 228 | $176K | |
| 77290 | 859 | 679 | $176K | |
| 77080 | 1,801 | 1,660 | $167K | |
| 47562 | 40 | 39 | $163K | |
| 94010 | 2,118 | 1,947 | $159K | |
| 82728 | 23,859 | 20,615 | $156K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 50,837 | 41,124 | $152K |
| P9016 | Red blood cells, leukocytes reduced, each unit | 2,173 | 1,456 | $150K |
| 86803 | 19,758 | 16,238 | $146K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 10,488 | 9,899 | $144K |
| 86480 | 3,812 | 3,138 | $140K | |
| 87536 | 3,406 | 2,805 | $139K | |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 560 | 329 | $137K |
| 88342 | 6,787 | 6,076 | $134K | |
| 96417 | 2,839 | 1,681 | $132K | |
| 77065 | Tomosynthesis, mammo | 1,313 | 1,171 | $131K |
| 96367 | 3,284 | 2,209 | $129K | |
| 0002A | 3,886 | 3,402 | $128K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 79,941 | 65,792 | $126K |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 110 | 64 | $123K |
| C8908 | Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral | 451 | 389 | $120K |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 9,572 | 9,059 | $120K |
| 76536 | 1,625 | 1,517 | $119K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 5,938 | 3,513 | $118K |
| 93975 | 675 | 619 | $117K | |
| 83550 | 28,243 | 22,607 | $116K | |
| 86235 | 2,358 | 1,590 | $116K | |
| 0001A | 4,064 | 3,412 | $114K | |
| 64493 | 118 | 104 | $113K | |
| 90677 | 729 | 672 | $113K | |
| 72100 | 6,331 | 5,676 | $111K | |
| 83013 | 2,402 | 2,114 | $111K | |
| 82374 | 198,856 | 148,370 | $110K | |
| 95816 | 953 | 845 | $110K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | 4,369 | 2,379 | $108K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 5,153 | 4,437 | $107K |
| 36591 | 4,918 | 3,215 | $107K | |
| 64483 | 160 | 152 | $105K | |
| 96416 | 630 | 323 | $104K | |
| 82746 | 15,420 | 12,841 | $104K | |
| 96411 | 2,059 | 1,174 | $102K | |
| 72158 | 530 | 490 | $101K | |
| 95911 | 272 | 250 | $100K | |
| 73562 | 8,152 | 7,261 | $99K | |
| 73030 | 7,950 | 6,936 | $98K | |
| 97162 | 3,508 | 2,895 | $97K | |
| 86870 | 715 | 560 | $95K | |
| 95912 | 260 | 238 | $93K | |
| 83970 | 5,168 | 4,130 | $90K | |
| 72110 | 1,758 | 1,604 | $88K | |
| 74174 | 716 | 643 | $88K | |
| 83540 | 28,825 | 23,087 | $88K | |
| 92557 | 1,234 | 1,155 | $87K | |
| 70491 | 542 | 506 | $83K | |
| 87070 | 22,439 | 18,464 | $82K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 86,568 | 58,043 | $77K |
| 75574 | 790 | 725 | $77K | |
| 10060 | 504 | 477 | $75K | |
| 87340 | 15,675 | 12,620 | $75K | |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 1,173 | 671 | $74K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 686 | 627 | $72K |
| 86592 | 23,775 | 19,623 | $72K | |
| 71271 | 794 | 722 | $72K | |
| 58571 | 16 | 12 | $71K | |
| 86360 | 3,582 | 2,705 | $71K | |
| 81513 | 813 | 740 | $70K | |
| 15830 | 12 | 12 | $69K | |
| 73610 | 6,766 | 5,874 | $69K | |
| 85027 | 41,831 | 33,709 | $69K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 10,895 | 9,649 | $68K |
| 80053 | Comprehensive metabolic panel | 38,266 | 26,802 | $68K |
| 80061 | Lipid panel | 20,334 | 16,425 | $68K |
| 96402 | 2,188 | 1,815 | $66K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 4,479 | 2,845 | $66K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 1,586 | 832 | $66K |
| 88184 | 565 | 498 | $65K | |
| 49083 | 112 | 77 | $62K | |
| 73502 | 4,917 | 4,286 | $61K | |
| 90686 | 8,293 | 7,612 | $61K | |
| 73564 | 1,252 | 1,054 | $60K | |
| 84153 | 6,778 | 5,894 | $59K | |
| 70486 | 3,249 | 3,001 | $56K | |
| 90732 | 921 | 832 | $56K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 328 | 306 | $56K |
| 83735 | 55,464 | 38,223 | $55K | |
| 87186 | 15,060 | 12,688 | $55K | |
| 73130 | 6,550 | 5,883 | $54K | |
| 72050 | 763 | 704 | $53K | |
| 74183 | 252 | 237 | $53K | |
| 93017 | 3,202 | 2,831 | $52K | |
| 82784 | 6,244 | 4,709 | $52K | |
| 86706 | 11,005 | 8,889 | $51K | |
| 73700 | 868 | 744 | $51K | |
| J1453 | Injection, fosaprepitant, 1 mg | 1,207 | 687 | $49K |
| 84425 | 4,349 | 2,873 | $49K | |
| 83880 | 15,645 | 13,293 | $49K | |
| 84439 | 10,689 | 9,095 | $49K | |
| 73630 | 8,281 | 7,173 | $48K | |
| 82570 | 18,738 | 16,149 | $48K | |
| 82652 | 2,463 | 1,599 | $47K | |
| 90746 | 956 | 862 | $46K | |
| 92587 | 186 | 179 | $45K | |
| 73110 | 3,970 | 3,477 | $44K | |
| 85610 | 54,991 | 40,350 | $43K | |
| G0330 | Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room | 71 | 52 | $43K |
| 72156 | 201 | 188 | $42K | |
| 86618 | 3,332 | 2,453 | $42K | |
| 86140 | 19,267 | 14,652 | $41K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 916 | 550 | $41K |
| 84207 | 3,480 | 2,041 | $40K | |
| 82043 | 12,273 | 10,948 | $39K | |
| 86334 | 4,985 | 3,842 | $39K | |
| 73590 | 3,623 | 3,229 | $39K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1,297 | 1,140 | $39K |
| 83655 | 4,187 | 3,812 | $39K | |
| 87522 | Neg quan hep c or qual rna | 1,700 | 1,417 | $37K |
| 80074 | 1,518 | 1,215 | $37K | |
| 83883 | 4,840 | 3,681 | $37K | |
| 82465 | 38,877 | 33,992 | $37K | |
| 90670 | 1,803 | 1,709 | $36K | |
| 88112 | 2,554 | 2,245 | $35K | |
| 84403 | 2,578 | 2,094 | $35K | |
| 86038 | 5,330 | 4,096 | $35K | |
| 73560 | 4,233 | 3,678 | $34K | |
| 84134 | 6,933 | 5,354 | $34K | |
| G0257 | Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility | 473 | 323 | $34K |
| 72131 | 746 | 668 | $34K | |
| 86160 | 2,717 | 1,876 | $34K | |
| 86704 | 5,749 | 4,702 | $33K | |
| 72070 | 1,373 | 1,247 | $32K | |
| J9395 | Injection, fulvestrant, 25 mg | 133 | 105 | $32K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 138 | 116 | $32K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 21 | 13 | $31K |
| 86920 | 4,027 | 2,583 | $31K | |
| 74018 | 4,150 | 3,605 | $31K | |
| 73551 | 2,334 | 2,101 | $30K | |
| G0379 | Direct admission of patient for hospital observation care | 34 | 27 | $30K |
| 74241 | 248 | 239 | $30K | |
| J0185 | Injection, aprepitant, 1 mg | 170 | 102 | $30K |
| 95909 | 144 | 130 | $30K | |
| 87077 | 8,537 | 7,242 | $29K | |
| 72040 | 2,502 | 2,251 | $29K | |
| 78306 | 138 | 122 | $28K | |
| 84702 | 10,826 | 8,270 | $27K | |
| 93798 | 303 | 52 | $27K | |
| 87147 | 10,813 | 9,620 | $26K | |
| 19083 | 35 | 29 | $26K | |
| G0378 | Hospital observation service, per hour | 21,285 | 17,545 | $26K |
| 73080 | 2,511 | 2,208 | $26K | |
| 52332 | 13 | 13 | $26K | |
| 80164 | 3,910 | 3,159 | $26K | |
| 85652 | 21,837 | 16,836 | $26K | |
| 88304 | 2,669 | 2,425 | $25K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 19,510 | 16,801 | $25K |
| 87088 | 6,602 | 5,831 | $24K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 10,874 | 9,035 | $23K |
| J2997 | Injection, alteplase recombinant, 1 mg | 344 | 264 | $23K |
| 82140 | 3,398 | 2,403 | $23K | |
| 97166 | 569 | 466 | $23K | |
| 96401 | 1,113 | 569 | $22K | |
| 84146 | 2,206 | 1,776 | $22K | |
| 84165 | 5,751 | 4,452 | $22K | |
| 81001 | 33,055 | 27,525 | $22K | |
| Q5118 | Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg | 33 | 14 | $20K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 242 | 231 | $20K |
| 84630 | 4,055 | 2,193 | $20K | |
| 73060 | 1,844 | 1,622 | $20K | |
| 86787 | 2,145 | 1,571 | $20K | |
| 74220 | 206 | 186 | $20K | |
| 84590 | 3,526 | 2,147 | $19K | |
| 70498 | 3,161 | 2,798 | $19K | |
| 72170 | 3,441 | 3,075 | $19K | |
| 84446 | 2,583 | 1,445 | $18K | |
| 86762 | 5,692 | 4,212 | $18K | |
| 90651 | 1,021 | 954 | $18K | |
| 96523 | 877 | 701 | $17K | |
| 87625 | 704 | 659 | $17K | |
| 83001 | 1,567 | 1,182 | $17K | |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 88 | 76 | $17K |
| 90734 | 876 | 821 | $17K | |
| 0031A | 867 | 453 | $17K | |
| 88173 | 1,250 | 986 | $17K | |
| 36593 | 95 | 79 | $16K | |
| 80202 | 1,398 | 479 | $16K | |
| 86200 | 2,333 | 1,721 | $16K | |
| 85730 | 22,427 | 18,734 | $15K | |
| 86147 | 463 | 300 | $15K | |
| 73140 | 1,490 | 1,349 | $15K | |
| 73090 | 2,076 | 1,827 | $15K | |
| 95910 | 62 | 60 | $15K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 18,377 | 16,839 | $15K |
| 95913 | 38 | 36 | $15K | |
| 77062 | 1,182 | 1,063 | $15K | |
| 84252 | 1,892 | 1,278 | $13K | |
| 87081 | 4,576 | 3,773 | $13K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 1,290 | 1,197 | $13K |
| 87493 | 618 | 492 | $13K | |
| 0004A | 397 | 332 | $13K | |
| 82180 | 2,831 | 1,428 | $13K | |
| 86431 | 4,286 | 3,141 | $12K | |
| 83516 | 1,160 | 883 | $12K | |
| 92551 | 1,979 | 1,858 | $11K | |
| 83690 | 54,706 | 47,263 | $11K | |
| 83021 | 2,786 | 2,246 | $11K | |
| 43235 | 41 | 39 | $11K | |
| 84255 | 694 | 465 | $11K | |
| 80076 | 7,429 | 6,069 | $10K | |
| 82378 | 3,166 | 2,302 | $10K | |
| 82105 | 1,302 | 1,037 | $10K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 44 | 42 | $10K |
| 82950 | 2,510 | 2,307 | $10K | |
| 83002 | 905 | 656 | $10K | |
| 74019 | 2,121 | 1,971 | $10K | |
| 84156 | 6,752 | 5,452 | $10K | |
| 82565 | 206,188 | 153,981 | $10K | |
| 86765 | 1,281 | 894 | $9K | |
| 80177 | 1,401 | 1,196 | $9K | |
| 20680 | 12 | 12 | $9K | |
| 86003 | 164 | 120 | $9K | |
| 86735 | 1,154 | 807 | $9K | |
| 0012A | 679 | 375 | $9K | |
| 87205 | 7,460 | 5,605 | $9K | |
| 76000 | 411 | 377 | $8K | |
| 84480 | 960 | 811 | $8K | |
| 83020 | 2,788 | 2,247 | $8K | |
| 86703 | 1,330 | 1,094 | $8K | |
| 86696 | 614 | 545 | $8K | |
| 81003 | 21,316 | 18,709 | $8K | |
| 72190 | 101 | 88 | $8K | |
| 87529 | 230 | 188 | $7K | |
| 84597 | 1,373 | 815 | $7K | |
| 84481 | 841 | 701 | $7K | |
| 86255 | 937 | 649 | $7K | |
| 88307 | 2,225 | 1,921 | $7K | |
| 31629 | 15 | 14 | $7K | |
| 20605 | 33 | 28 | $7K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 11,860 | 10,402 | $7K |
| 82248 | 64,887 | 54,759 | $7K | |
| 95250 | 87 | 80 | $6K | |
| 87040 | 8,719 | 7,330 | $6K | |
| 86376 | 786 | 590 | $6K | |
| 85045 | 4,098 | 3,348 | $6K | |
| 0064A | 181 | 154 | $6K | |
| 93880 | 122 | 107 | $6K | |
| 87150 | 420 | 370 | $6K | |
| 93270 | 406 | 336 | $6K | |
| 74240 | 56 | 52 | $6K | |
| 86695 | 614 | 545 | $5K | |
| 84478 | 38,861 | 33,939 | $5K | |
| 77280 | 96 | 65 | $5K | |
| 74178 | 25 | 24 | $5K | |
| 86300 | 2,028 | 1,436 | $5K | |
| 80185 | 816 | 561 | $5K | |
| 86304 | 863 | 636 | $5K | |
| 86708 | 853 | 575 | $5K | |
| 72197 | 14 | 12 | $5K | |
| 83615 | 58,412 | 49,447 | $5K | |
| 86812 | 277 | 214 | $5K | |
| 82525 | 838 | 426 | $5K | |
| 86769 | 124 | 116 | $5K | |
| 85379 | 8,083 | 7,253 | $5K | |
| 82670 | 274 | 205 | $4K | |
| J1610 | Injection, glucagon hydrochloride, per 1 mg | 43 | 37 | $4K |
| 31624 | 55 | 48 | $4K | |
| 87184 | 1,575 | 1,362 | $4K | |
| 86880 | 1,553 | 1,030 | $4K | |
| 82550 | 13,546 | 10,300 | $4K | |
| 83010 | 1,188 | 948 | $4K | |
| 0011A | 669 | 313 | $4K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 288 | 129 | $4K |
| 36589 | 15 | 13 | $4K | |
| 82164 | 540 | 356 | $4K | |
| 86800 | 448 | 337 | $4K | |
| 86146 | 133 | 84 | $4K | |
| 77470 | 16 | 13 | $4K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 112 | 69 | $4K |
| 86225 | 507 | 371 | $4K | |
| 82150 | 41,683 | 36,468 | $4K | |
| 84550 | 9,248 | 7,399 | $4K | |
| 77307 | 17 | 12 | $4K | |
| 90832 | Psychotherapy, 30 minutes with patient | 93 | 83 | $3K |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | 368 | 235 | $3K |
| 88360 | 599 | 503 | $3K | |
| 84703 | 5,736 | 5,231 | $3K | |
| 84145 | 8,296 | 7,357 | $3K | |
| 85018 | 4,058 | 2,960 | $3K | |
| 85014 | 5,177 | 3,920 | $3K | |
| 83525 | 411 | 303 | $3K | |
| 86364 | 237 | 204 | $3K | |
| 87486 | 138 | 116 | $3K | |
| 87581 | 138 | 116 | $3K | |
| 73521 | 87 | 80 | $3K | |
| 93308 | 16 | 16 | $3K | |
| 71100 | 1,010 | 924 | $3K | |
| 87046 | 771 | 610 | $3K | |
| 87324 | 581 | 450 | $3K | |
| 84436 | 740 | 641 | $3K | |
| 87045 | 768 | 608 | $2K | |
| 0054A | 102 | 69 | $2K | |
| 36600 | 448 | 391 | $2K | |
| 95249 | 56 | 56 | $2K | |
| 84100 | 13,974 | 10,298 | $2K | |
| 84466 | 358 | 288 | $2K | |
| 86694 | 214 | 188 | $2K | |
| 87449 | 489 | 375 | $2K | |
| 84132 | 201,246 | 149,940 | $2K | |
| 84484 | 45,035 | 35,706 | $2K | |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | 28 | 26 | $2K |
| 86850 | 34,217 | 26,766 | $2K | |
| 73221 | 12 | 12 | $2K | |
| 12001 | 1,557 | 1,466 | $2K | |
| 73552 | 157 | 143 | $2K | |
| 82330 | 1,308 | 1,025 | $2K | |
| 82951 | 167 | 161 | $2K | |
| 21310 | 14 | 12 | $2K | |
| 84450 | 129,608 | 103,015 | $2K | |
| 31623 | 20 | 16 | $2K | |
| 90656 | 130 | 126 | $2K | |
| 20552 | 13 | 12 | $2K | |
| 81025 | 28,669 | 25,799 | $2K | |
| 87075 | 1,839 | 1,377 | $1K | |
| 93923 | 14 | 14 | $1K | |
| 80178 | 521 | 403 | $1K | |
| 82962 | 73,880 | 48,994 | $1K | |
| 73600 | 141 | 122 | $1K | |
| 86617 | 101 | 72 | $1K | |
| 92950 | 13 | 12 | $1K | |
| 85613 | 295 | 150 | $1K | |
| 84075 | 128,376 | 101,879 | $1K | |
| 86901 | 34,374 | 26,871 | $1K | |
| 82533 | 152 | 120 | $1K | |
| 86141 | 197 | 164 | $1K | |
| 81050 | 515 | 419 | $1K | |
| 74230 | 12 | 12 | $1K | |
| 86780 | 114 | 90 | $1K | |
| 87517 | 35 | 25 | $981.84 | |
| 73000 | 32 | 27 | $942.03 | |
| 83605 | 19,483 | 16,526 | $915.55 | |
| 82435 | 199,037 | 148,521 | $913.81 | |
| 83721 | 190 | 167 | $896.43 | |
| 92611 | 12 | 12 | $848.64 | |
| 84460 | 129,574 | 103,081 | $842.79 | |
| 87255 | 51 | 42 | $842.00 | |
| 94727 | 4,953 | 4,572 | $821.53 | |
| 82803 | 5,581 | 4,740 | $819.69 | |
| 83993 | 65 | 51 | $807.42 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 151 | 134 | $799.85 |
| 86301 | 210 | 153 | $797.31 | |
| 97116 | 45 | 27 | $789.48 | |
| 73200 | 13 | 12 | $788.66 | |
| 31628 | 23 | 19 | $742.50 | |
| 87269 | 131 | 110 | $740.88 | |
| 87272 | 131 | 110 | $730.42 | |
| 84270 | 56 | 42 | $730.33 | |
| 80162 | 163 | 122 | $717.85 | |
| 93225 | 13 | 12 | $713.02 | |
| 87503 | 514 | 442 | $710.26 | |
| 89050 | 1,448 | 1,104 | $706.75 | |
| 12011 | 572 | 530 | $681.11 | |
| 77061 | 51 | 50 | $672.40 | |
| 76813 | 5,922 | 5,310 | $611.87 | |
| 97161 | 25 | 24 | $605.46 | |
| 84520 | 201,762 | 150,665 | $557.61 | |
| 82785 | 53 | 43 | $543.90 | |
| 84155 | 79,273 | 60,967 | $526.14 | |
| 87338 | 56 | 51 | $524.47 | |
| 86039 | 93 | 76 | $521.02 | |
| 88300 | 257 | 227 | $518.09 | |
| 72020 | 142 | 127 | $484.90 | |
| 82952 | 139 | 133 | $474.98 | |
| 92567 | 1,521 | 1,415 | $465.91 | |
| 83921 | 59 | 51 | $455.00 | |
| 86705 | 62 | 52 | $450.00 | |
| 86611 | 20 | 12 | $437.40 | |
| J2310 | Injection, naloxone hydrochloride, per 1 mg | 266 | 227 | $413.90 |
| 90715 | 8,300 | 7,579 | $413.56 | |
| 86308 | 188 | 165 | $405.08 | |
| 73620 | 59 | 52 | $394.04 | |
| 12002 | 713 | 659 | $337.58 | |
| 87427 | 35 | 27 | $329.03 | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 26 | 26 | $326.60 |
| 96376 | 14,847 | 10,003 | $312.91 | |
| 86665 | 19 | 13 | $311.76 | |
| 82553 | 6,314 | 4,700 | $307.45 | |
| 87209 | 32 | 29 | $305.50 | |
| Q0114 | Fern test | 43 | 42 | $273.20 |
| 90621 | 13 | 13 | $265.74 | |
| 80156 | 82 | 64 | $256.87 | |
| 82077 | 12,137 | 10,208 | $248.39 | |
| 93041 | 17,687 | 15,988 | $247.84 | |
| 76827 | 738 | 618 | $244.28 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 2,770 | 2,417 | $243.40 |
| 86258 | 12 | 12 | $242.44 | |
| 82085 | 46 | 28 | $231.75 | |
| 86335 | 16 | 12 | $229.26 | |
| 84295 | 200,164 | 149,349 | $223.17 | |
| 87177 | 32 | 29 | $222.45 | |
| 86682 | 17 | 12 | $211.14 | |
| 86593 | 75 | 54 | $189.75 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 41,183 | 36,556 | $181.57 |
| 51701 | 1,613 | 1,465 | $173.00 | |
| 89060 | 99 | 89 | $171.99 | |
| 84402 | 17 | 12 | $170.24 | |
| 84300 | 222 | 199 | $163.63 | |
| 82731 | 34 | 25 | $157.64 | |
| 82375 | 524 | 456 | $153.01 | |
| 87420 | 13 | 12 | $148.85 | |
| 80051 | 35 | 32 | $147.40 | |
| 96368 | 1,004 | 641 | $144.35 | |
| 82009 | 2,899 | 2,559 | $139.59 | |
| 81002 | 14,080 | 12,979 | $136.17 | |
| 36592 | 177 | 155 | $135.02 | |
| 87481 | 148 | 146 | $134.04 | |
| 86664 | 19 | 13 | $131.49 | |
| 83930 | 353 | 317 | $126.20 | |
| 83520 | 20 | 12 | $123.60 | |
| 83090 | 28 | 20 | $118.48 | |
| 86663 | 19 | 13 | $112.77 | |
| 84154 | 13 | 12 | $105.36 | |
| 87102 | 22 | 14 | $104.26 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 101 | 101 | $100.35 |
| 85660 | 63 | 49 | $84.49 | |
| 76870 | 536 | 491 | $79.99 | |
| 70360 | 44 | 43 | $69.15 | |
| 73660 | 15 | 15 | $69.15 | |
| 87511 | 148 | 146 | $67.02 | |
| 82800 | 1,523 | 1,348 | $64.90 | |
| 88313 | 2,896 | 2,636 | $64.65 | |
| C1760 | Closure device, vascular (implantable/insertable) | 757 | 710 | $62.25 |
| 51702 | 342 | 293 | $58.97 | |
| 87207 | 30 | 15 | $55.02 | |
| 82977 | 37 | 25 | $54.45 | |
| 82960 | 14 | 12 | $53.55 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 29,976 | 26,369 | $50.34 |
| 87400 | 959 | 820 | $49.07 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 23,426 | 20,753 | $46.61 |
| 81015 | 2,156 | 1,938 | $43.16 | |
| 87653 | 51 | 49 | $33.51 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 8,542 | 5,209 | $29.61 |
| 86777 | 14 | 13 | $27.50 | |
| J0571 | Buprenorphine, oral, 1 mg | 70 | 48 | $25.81 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,641 | 1,548 | $25.38 |
| 99157 | 589 | 562 | $20.75 | |
| 99156 | 589 | 562 | $20.75 | |
| J1815 | Injection, insulin, per 5 units | 8,492 | 3,965 | $19.41 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 39,032 | 33,664 | $18.17 |
| J1836 | Injection, metronidazole, 10 mg | 569 | 318 | $16.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 9,794 | 7,691 | $15.33 |
| 82945 | 31 | 25 | $15.00 | |
| J0736 | Injection, clindamycin phosphate, 300 mg | 94 | 77 | $13.62 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 2,064 | 1,851 | $13.58 |
| J3490 | Unclassified drugs | 132,041 | 61,472 | $12.27 |
| J1644 | Injection, heparin sodium, per 1000 units | 15,329 | 8,210 | $12.14 |
| J1170 | Injection, hydromorphone, up to 4 mg | 27,439 | 16,825 | $11.85 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 45,863 | 38,070 | $10.45 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 10,048 | 8,115 | $10.36 |
| C1729 | Catheter, drainage | 881 | 664 | $9.55 |
| 82272 | 2,171 | 2,016 | $9.45 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 10,182 | 8,720 | $7.96 |
| C9113 | Injection, pantoprazole sodium, per vial | 3,501 | 2,215 | $7.85 |
| 85362 | 15 | 12 | $6.58 | |
| 83935 | 12 | 12 | $6.51 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 282 | 245 | $6.09 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 9,652 | 7,431 | $4.84 |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 37 | 36 | $4.21 |
| J3370 | Injection, vancomycin hcl, 500 mg | 4,216 | 2,620 | $3.38 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 6,095 | 5,439 | $2.45 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 569 | 503 | $2.42 |
| G0008 | Administration of influenza virus vaccine | 3,565 | 3,174 | $2.04 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 9,828 | 8,012 | $1.91 |
| C1769 | Guide wire | 7,241 | 6,362 | $1.41 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 21,788 | 18,642 | $1.40 |
| J1920 | Injection, labetalol hydrochloride, 5 mg | 207 | 155 | $1.24 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 6,194 | 5,052 | $1.01 |
| J0690 | Injection, cefazolin sodium, 500 mg | 14,692 | 11,933 | $1.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 2,741 | 1,771 | $1.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 534 | 366 | $0.45 |
| J2060 | Injection, lorazepam, 2 mg | 8,281 | 6,742 | $0.39 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 101 | 83 | $0.36 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 98 | 83 | $0.34 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 4,509 | 3,927 | $0.10 |
| C1758 | Catheter, ureteral | 847 | 740 | $0.00 |
| J0640 | Injection, leucovorin calcium, per 50 mg | 385 | 186 | $0.00 |
| 93325 | 1,509 | 1,273 | $0.00 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 2,548 | 2,130 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 811 | 568 | $0.00 |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | 462 | 385 | $0.00 |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 1,946 | 1,789 | $0.00 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 2,809 | 2,481 | $0.00 |
| 91300 | 7,762 | 6,366 | $0.00 | |
| J1756 | Injection, iron sucrose, 1 mg | 9,538 | 3,790 | $0.00 |
| 90681 | 271 | 266 | $0.00 | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 1,574 | 1,369 | $0.00 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 5,405 | 3,987 | $0.00 |
| 76376 | 455 | 403 | $0.00 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 7,042 | 5,042 | $0.00 |
| 90714 | 301 | 283 | $0.00 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 970 | 770 | $0.00 |
| 76937 | 878 | 742 | $0.00 | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 2,496 | 2,199 | $0.00 |
| 99152 | 3,309 | 3,037 | $0.00 | |
| 80143 | 651 | 584 | $0.00 | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 4,497 | 4,067 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 1,098 | 955 | $0.00 |
| J9190 | Injection, fluorouracil, 500 mg | 1,351 | 376 | $0.00 |
| 94729 | 5,533 | 5,095 | $0.00 | |
| J1953 | Injection, levetiracetam, 10 mg | 1,147 | 888 | $0.00 |
| J1240 | Injection, dimenhydrinate, up to 50 mg | 2,777 | 2,537 | $0.00 |
| 87210 | 220 | 202 | $0.00 | |
| 90633 | 456 | 445 | $0.00 | |
| 80179 | 555 | 502 | $0.00 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 2,476 | 2,266 | $0.00 |
| 90713 | 272 | 268 | $0.00 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 192 | 159 | $0.00 |
| 90648 | 669 | 653 | $0.00 | |
| J0692 | Injection, cefepime hydrochloride, 500 mg | 611 | 426 | $0.00 |
| C1776 | Joint device (implantable) | 1,473 | 1,181 | $0.00 |
| S0077 | Injection, clindamycin phosphate, 300 mg | 78 | 64 | $0.00 |
| J3489 | Injection, zoledronic acid, 1 mg | 177 | 155 | $0.00 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 329 | 91 | $0.00 |
| 93356 | 523 | 467 | $0.00 | |
| 90671 | 70 | 70 | $0.00 | |
| 95251 | 37 | 30 | $0.00 | |
| 29125 | 137 | 130 | $0.00 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 142 | 118 | $0.00 |
| 90710 | 215 | 211 | $0.00 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 329 | 302 | $0.00 |
| 90700 | 13 | 13 | $0.00 | |
| 76942 | 74 | 63 | $0.00 | |
| C1788 | Port, indwelling (implantable) | 134 | 104 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 90 | 80 | $0.00 |
| 90685 | 272 | 266 | $0.00 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 333 | 283 | $0.00 |
| J0744 | Injection, ciprofloxacin for intravenous infusion, 200 mg | 110 | 85 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 627 | 577 | $0.00 |
| M1145 | Most favored nation (mfn) model drug add-on amount, per dose, (do not bill with line items that have the jw modifier) | 16 | 16 | $0.00 |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | 24 | 12 | $0.00 |
| 97803 | 65 | 65 | $0.00 | |
| C1874 | Stent, coated/covered, with delivery system | 63 | 60 | $0.00 |
| 77012 | 40 | 36 | $0.00 | |
| 82805 | 56 | 55 | $0.00 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 32 | 27 | $0.00 |
| A9541 | Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | 13 | 12 | $0.00 |
| 88312 | 13 | 12 | $0.00 | |
| 99153 | Mod sedat endo service >5yrs | 3,224 | 2,955 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 2,070 | 1,820 | $0.00 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 6,589 | 4,383 | $0.00 |
| A4648 | Tissue marker, implantable, any type, each | 380 | 339 | $0.00 |
| 95885 | 44 | 42 | $0.00 | |
| 88341 | 2,933 | 2,488 | $0.00 | |
| J9267 | Injection, paclitaxel, 1 mg | 639 | 266 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 423 | 394 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 3,967 | 3,287 | $0.00 |
| J1940 | Injection, furosemide, up to 20 mg | 2,770 | 1,915 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 5,625 | 5,012 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 9,980 | 5,135 | $0.00 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 1,882 | 1,170 | $0.00 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 587 | 476 | $0.00 |
| 88311 | 546 | 353 | $0.00 | |
| 77001 | 661 | 566 | $0.00 | |
| G0009 | Administration of pneumococcal vaccine | 1,353 | 1,202 | $0.00 |
| 76820 | 2,396 | 1,022 | $0.00 | |
| C1781 | Mesh (implantable) | 230 | 211 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 482 | 402 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 278 | 146 | $0.00 |
| Q3014 | Telehealth originating site facility fee | 920 | 763 | $0.00 |
| 95886 | 2,439 | 2,243 | $0.00 | |
| J1720 | Injection, hydrocortisone sodium succinate, up to 100 mg | 237 | 166 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 37,985 | 28,513 | $0.00 |
| J3411 | Injection, thiamine hcl, 100 mg | 263 | 205 | $0.00 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 1,391 | 1,155 | $0.00 |
| G0010 | Administration of hepatitis b vaccine | 244 | 225 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 2,496 | 2,314 | $0.00 |
| 94660 | 528 | 304 | $0.00 | |
| 88185 | 568 | 498 | $0.00 | |
| J9045 | Injection, carboplatin, 50 mg | 566 | 301 | $0.00 |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 884 | 776 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 1,716 | 1,435 | $0.00 |
| J0280 | Injection, aminophyllin, up to 250 mg | 634 | 561 | $0.00 |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 259 | 231 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 723 | 603 | $0.00 |
| 91305 | 198 | 126 | $0.00 | |
| J0456 | Injection, azithromycin, 500 mg | 214 | 158 | $0.00 |
| 94761 | 200 | 183 | $0.00 | |
| 91301 | 875 | 726 | $0.00 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 445 | 397 | $0.00 |
| 90619 | 96 | 86 | $0.00 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 218 | 202 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 1,508 | 1,329 | $0.00 |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 229 | 188 | $0.00 |
| 0399T | 119 | 108 | $0.00 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 33 | 27 | $0.00 |
| C2617 | Stent, non-coronary, temporary, without delivery system | 64 | 56 | $0.00 |
| 91303 | 864 | 450 | $0.00 | |
| A9503 | Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 274 | 252 | $0.00 |
| 51798 | 139 | 120 | $0.00 | |
| 90696 | 67 | 65 | $0.00 | |
| 91306 | 159 | 134 | $0.00 | |
| 12013 | 28 | 27 | $0.00 | |
| C2627 | Catheter, suprapubic/cystoscopic | 205 | 171 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 135 | 104 | $0.00 |
| 64494 | 72 | 62 | $0.00 | |
| G0475 | Hiv antigen/antibody, combination assay, screening | 175 | 174 | $0.00 |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 95 | 94 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 316 | 278 | $0.00 |
| J1805 | Injection, esmolol hydrochloride, 10 mg | 17 | 15 | $0.00 |
| 86905 | 19 | 12 | $0.00 | |
| C1726 | Catheter, balloon dilatation, non-vascular | 28 | 26 | $0.00 |
| 77417 | 29 | 14 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 14 | 14 | $0.00 |
| J3360 | Injection, diazepam, up to 5 mg | 67 | 56 | $0.00 |
| 76377 | 27 | 27 | $0.00 | |
| 11045 | 18 | 12 | $0.00 | |
| 96377 | 17 | 12 | $0.00 | |
| 95012 | 12 | 12 | $0.00 | |
| 99292 | 13 | 12 | $0.00 | |
| 97802 | 21 | 21 | $0.00 | |
| 31654 | 15 | 12 | $0.00 |